<SEC-DOCUMENT>0001575872-24-001217.txt : 20241202
<SEC-HEADER>0001575872-24-001217.hdr.sgml : 20241202
<ACCEPTANCE-DATETIME>20241202062826
ACCESSION NUMBER:		0001575872-24-001217
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		5
CONFORMED PERIOD OF REPORT:	20241201
FILED AS OF DATE:		20241202
DATE AS OF CHANGE:		20241202

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			DR REDDYS LABORATORIES LTD
		CENTRAL INDEX KEY:			0001135951
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				000000000
		FISCAL YEAR END:			0331

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-15182
		FILM NUMBER:		241517379

	BUSINESS ADDRESS:	
		STREET 1:		8-2-337, ROAD NO.3 BANJARA HILLS
		CITY:			HYDERABAD
		STATE:			K7
		ZIP:			500-034
		BUSINESS PHONE:		91 40 49002900

	MAIL ADDRESS:	
		STREET 1:		8-2-337, ROAD NO.3 BANJARA HILLS
		CITY:			HYDERABAD
		STATE:			K7
		ZIP:			500-034
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>drr0702_6k.htm
<DESCRIPTION>FORM 6-K
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="margin-top: 0pt; font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid; margin-bottom: 0pt">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">SECURITIES AND EXCHANGE COMMISSION</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Washington, D.C. 20549</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Form 6-K</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE
13A-16 OR 15D-16 </B></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">UNDER THE SECURITIES EXCHANGE ACT OF 1934</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">December, 2024</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Commission File Number 1-15182</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: bold 24pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="text-transform: none">DR.
REDDY&rsquo;S LABORATORIES LIMITED</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Translation of registrant&rsquo;s name into English)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>8-2-337, Road No. 3, Banjara Hills</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Hyderabad, Telangana 500 034, India</B></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">+91-40-49002900</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Address of principal executive office)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Indicate by check mark whether the registrant files or will file annual
reports under cover of Form 20-F or Form 40-F.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form
20-F </FONT><FONT STYLE="font-family: Wingdings; font-size: 10pt">x</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form
40-F </FONT><FONT STYLE="font-family: Wingdings; font-size: 10pt">&uml;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Indicate by check mark if the registrant is submitting the Form 6-K in
paper as permitted by Regulation S-T Rule 101(b)(1): ______</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Note:</B> Regulation S-T Rule 101(b)(1) only permits the submission
in paper of a Form 6-K if submitted solely to provide an attached annual report to security holders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Indicate by check mark if the registrant is submitting the Form 6-K in
paper as permitted by Regulation S-T Rule 101(b)(7): ______</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Note: </B>Regulation S-T Rule 101(b)(7) only permits
the submission in paper of a Form 6-K if submitted to furnish a report or other document that the registrant foreign private issuer must
furnish and make public under the laws of the jurisdiction in which the registrant is incorporated, domiciled or legally organized (the
registrant&rsquo;s &ldquo;home country&rdquo;), or under the rules of the home country exchange on which the registrant&rsquo;s securities
are traded, as long as the report or other document is not a press release, is not required to be and has not been distributed to the
registrant&rsquo;s security holders, and, if discussing a material event, has already been the subject of a Form 6-K submission or other
Commission filing on EDGAR.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether by furnishing the information
contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the
Securities Exchange Act of 1934.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yes
</FONT><FONT STYLE="font-family: Wingdings; font-size: 10pt">&uml;</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
</FONT><FONT STYLE="font-family: Wingdings; font-size: 10pt">x</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">If &ldquo;Yes&rdquo; is marked, indicate below the file number assigned
to registrant in connection with Rule 12g3-2(b): 82-________.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B></B></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="margin-top: 0pt; font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid; margin-bottom: 0pt">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 0pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>EXHIBITS </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; white-space: nowrap">
    <P STYLE="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Exhibit<BR>
    Number</B></P></TD>
    <TD STYLE="padding-bottom: 1pt; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Description of Exhibits</B></FONT></TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="white-space: nowrap; vertical-align: top; font-size: 10pt"><A HREF="drr0702_ex99-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1</FONT></A></TD>
    <TD STYLE="vertical-align: bottom; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; font-size: 10pt"><A HREF="drr0702_ex99-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">Intimation dated December 01, 2024 </FONT></A></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 0pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>SIGNATURES </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">DR. REDDY&rsquo;S LABORATORIES LIMITED</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(Registrant)</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date: December 01, 2024 </FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ K Randhir Singh</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 5%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="width: 40%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">K Randhir Singh</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company Secretary </FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3; Options: Last -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>drr0702_ex99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><B>Exhibit 99.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 64%"><IMG SRC="drr0702_ex99-1img01.jpg" ALT="">&nbsp;</TD>
    <TD STYLE="width: 36%">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Dr. Reddy&rsquo;s Laboratories Ltd.</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>8-2-337, Road No. 3, Banjara Hills,</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Hyderabad - 500 034, Telangana,</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>India.</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>CIN : L85195TG1984PLC004507</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Tel&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;: +91 40 4900 2900</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Fax&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;: +91 40 4900 2999</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Email&nbsp; : mail@drreddys.com</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>www.drreddys.com</B></P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">December 01, 2024</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">National Stock Exchange of India Ltd. (Scrip Code: DRREDDY-EQ)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">BSE Ltd. (Scrip Code: 500124)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">New York Stock Exchange Inc. (Stock Code: RDY)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">NSE IFSC Ltd. (Stock Code: DRREDDY)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Dear Sir/Madam,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>Ref:</B></TD><TD STYLE="text-align: justify"><B><U>Disclosure under Regulation 30 of the SEBI (Listing Obligations &amp; Disclosure Requirements) Regulations,
2015</U></B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 28.35pt; text-align: justify; text-indent: -28.35pt"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>Sub:</B></TD><TD><B><U>Allotment of Equity Shares on exercise of Stock Options under ESOPs</U></B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">This is to inform you that the Nomination, Governance
and Compensation Committee of the Board of Directors of the Company has approved the allotment of 26,150 equity shares of Re.1/- each
of the Company, fully paid up, on December 01, 2024, to employees pursuant to exercise of their Stock Options, as per the following details:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">a)</TD><TD STYLE="text-align: justify">26,150 equity shares of Re.1/- each pursuant to Dr. Reddy&rsquo;s Employees Stock Options Scheme, 2002.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Further, please find enclosed the details as required
under Regulation 10(c) of the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Thanking you.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Yours faithfully,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">For <B>Dr. Reddy&rsquo;s Laboratories Limited</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><IMG SRC="drr0702_ex99-1img02.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>K Randhir Singh</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><I>Company Secretary, Compliance Officer &amp; Head-CSR</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Encl: as above</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 64%">&nbsp;<IMG SRC="drr0702_ex99-1img01.jpg" ALT=""></TD>
    <TD STYLE="width: 36%">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Dr. Reddy&rsquo;s Laboratories Ltd.</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>8-2-337, Road No. 3, Banjara Hills,</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Hyderabad - 500 034, Telangana,</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>India.</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>CIN : L85195TG1984PLC004507</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Tel&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;: +91 40 4900 2900</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Fax&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;: +91 40 4900 2999</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Email&nbsp; : mail@drreddys.com</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>www.drreddys.com</B></P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>Details under Regulation 10(c) of the SEBI (Share
Based Employee Benefits and Sweat Equity) Regulations, 2021</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="4" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="white-space: nowrap; width: 7%; border: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">1</FONT></TD>
    <TD STYLE="width: 93%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt"><B>Company name and address of Registered Office:</B><BR>
Dr. Reddy's Laboratories Limited<BR>
8-2-337, Road No.3, Banjara Hills, Hyderabad &ndash; 500034</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">2</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Name of the Stock Exchanges on which the company&rsquo;s shares are
    listed:</B><BR>
    BSE Limited<BR>
    National Stock Exchange of India Limited<BR>
    New York Stock Exchange Inc. (ADRs)</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">NSE IFSC Limited (ADRs)</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">3</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>Filing date of the statement referred in Regulation
    10(b) of the SEBI (Share Based Employee Benefits) Regulations, 2021 with Stock Exchange:</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Schemes were institutionalised under the erstwhile
    the SEBI (Employee Stock Option Scheme and Employee Stock Purchase Scheme) Guidelines, 1999 and appropriate details under Schedule V were
    filed. The Schemes comply with provisions of the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021.</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">4</FONT></TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt"><B>Filing Number, if any:</B> NA</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">5</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt"><B>Title of the Scheme pursuant to which shares are issued, if any: </B><BR>
1. Dr. Reddy&rsquo;s Employees Stock Options Scheme, 2002</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">6</FONT></TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt"><B>Kind of security to be listed:</B> Equity Shares </FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">7</FONT></TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt"><B>Par value of the shares: </B>Re. 1/-</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">8</FONT></TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt"><B>Date of issue of shares: </B>December 01, 2024 (Date of allotment on exercise)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">9</FONT></TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt"><B>Number of shares issued:</B> 26,150 equity shares</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">10</FONT></TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt"><B>Share Certificate No., if applicable: </B>NA</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">11</FONT></TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt"><B>Distinctive number of the share, if applicable: </B>834384731 to 834410880</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">12</FONT></TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt"><B>ISIN Number of the shares if issued in Demat:</B> INE089A01031</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">13</FONT></TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Exercise price per share:</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 136.1pt; text-indent: -0.25in">1.&nbsp;&nbsp;&nbsp;&nbsp;26,150 equity
    shares exercised at Re.1/- per share</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">14</FONT></TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Premium per share:</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -0.25in">a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;26,150
    equity shares- Nil</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;15</FONT></TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt"><B>Total Issued shares after this issue: </B>&nbsp;83,44,11,880 (*)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">16</FONT></TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt"><B>Total Issued share capital after this issue: </B>Rs.83,44,11,880/-</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">17</FONT></TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt"><B>Details of any lock-in on the shares:</B> NA</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">18</FONT></TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt"><B>Date of expiry of lock-in:</B>&nbsp;&nbsp;NA</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">19</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt"><B>Whether shares identical in all respects to existing shares if not, when will they become identical?</B> <BR>
Yes, the shares rank pari passu with the existing shares</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">20</FONT></TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt"><B>Details of listing fees, if payable: </B>NA</FONT></TD></TR>
  </TABLE>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">(*)</TD><TD STYLE="text-align: justify">Total paid up capital after this issue: 83,44,10,880 equity shares of Re.1 each, aggregating to Rs. 83,44,10,880
(difference of 1,000 due to forfeited shares of Re. 1/- each in September 1988 on account of non-payment of allotment money.)</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: right; text-indent: -0.25in"><IMG SRC="drr0702_ex99-1img03.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; text-indent: -0.25in">&nbsp;</P>


<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>drr0702_ex99-1img01.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 drr0702_ex99-1img01.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  L +<# 2(  A$! Q$!_\0
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MV@/"%_XHL_".J76K^'Y]*\1:QX:U'3+R[MOL=T(M2T2[TZY>&>( $$%2$4J
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MJO;>R]J^?V,J<H<]I?P>945._P#$]C"7)3Y[\J5U9MH****S&?@7_P %8_\
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GW>4N57=DDL%"/M)56KU9QA"=1_%*%/F]G%^4.>5O\3"BBBL"S__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>drr0702_ex99-1img02.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 drr0702_ex99-1img02.jpg
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MQ "-   " P$! 0$            $!0 #!@(' 0@! 0$! 0
M   ! @,0  (" 0,# @4" P8$!P$   (# 00%$1(& "$3,0=!42(R%&$C<4(5
M4F(S)#07@9%R4_"Q@I(E%G<($0$!  (!! (!!0           1$",2%!$@,B
M,E%A@9%"$__:  P# 0 "$0,1 #\ ]0X[[H<FY*NIA<2-4N2-O7IR=B5D5>AB
MZ=]M<&L#?$DYXJV*#=WG4IT&.@UG"^59+-(Y0=L51.'S-['5/&,CJFL(2$GK
M,ZE]4ZS&G081WO-R.KQ[VYS-A-8D<@1-SDTP!1XJT$A1M3]4[8 [4%.NO:.@
MTO)?<3*T?=/CO%:"TGB[)>/./.)E@-LHL-IK7,%$#/\ DS(M8GM,=!5E/<K*
MU?=.K@EI3/%P<C%9&W,%Y0REVNVU7 2UV[-BP$NWW,CH)F^3\Y?S+DF*PM_&
MXZEQS&T[_P#GZK'0X[,6)*&-"PGQ ,5_N@9]>@U_"^0,Y%Q+#YYM::;,I33;
M.J4Z^.7!!R.LQ&L=^T_+H'/03H*+DSXH'TWF(S_"9[]39T]7)+R[(Y#&X^H.
M,8";%W(5:?E8'E%8V&P!S ;@UF(GMWZL8MRSR_<7(4KS<=>6N_:0]]%)U1A2
MK+X=24F=QF?BT*_L9'U:2,_H/1'#_<S+G;0FEC5PXK:J5FJ]L;0*<BV@TQ<$
M%N[IU&-OQ[_+H*<][I697;7BEBIM,W$-B?W4O1^!?<EBRD0U_>H_5IK'R*>@
MTF!YH.3R+<5^(R+])1LR$1(Z!I(?CS'S_) Y,/E$3KT"A/N<3G5Q&E/Y-D%J
M#&D4":[;;4HA3V% ^(@@=3'9.GPW=M0LQ_ND-NPH)Q+5(AR:UQWF67A99N6*
M*X@1_P 2/+5G=,?"8]?3H.*OND5]*(H8>Q+[PR['2Z? EM>$DXF>5@".\1&-
MP#N[E'U::S 5%SW.5L=QJ^54;P7L _+Y-0DM$[D!581A)=O1QZ#Z3.FLQ'?H
M"_\ =3'S;BH%!Y6!.1>J)C<L2+R**8]?W*@LL1']D)CUZ#&<>]M>2\:QM;D^
M(QHKY=4RV1;DJ ,4,Y/%W;QEX6,W;/(*O&U,F7TD.V=-9Z!TBESWB]SE-+#\
M?G,UN07793%WHLUT AUM0 U5P&D+(%; W02A/49TTUZ 97M+;@..<;M1%C"8
M[BF0P=V_$CI-FY^*'TA,[^\*,AG3MI\^@$P? ><+Q/&\EF$"[E$\DK9//R#%
MS 5:U-F/"8*2T+1, >T>^I3T SO:#DF2X1ELK8MW:G-LC;?GDXH;0_AA?6[R
MTED S*YD%I4N2W:=N@8Y3VH'F/)^2Y+DN)A(9/#8U&+>31DZ]P!L$^!\9SW4
M9K[S])?K&O0>A\,//%Q/$3R!'X^<&HH,DF) HBP 0+)B5S(:$4:QIT#GH)T%
M%Z)_&(H]0F"_]LZ]9VX=/3]BW.%QUN,6&>6IU"S96M8/#R!+B9^S/I.FA1$[
MOAU8F\Q<$EBUP"]QZR%>$U:%:F$PP:8S"JMUNH2"G*,"!S$;OMG72"^4]5@/
MB/\ ;/'8=-*#3:4S*'A_(]$2QF2BV;I5M!8P.VQN,=HP ^L=N_0%'9]LJI9<
M I59;1LIKY-**<L.;%R"6H($%S+)9^48?3K]Q1/\W064LGQ'&5VYI1OLSR"S
M*-!K-:\CK+,(JQ74KR -<$,C:0:QH6O>>@H:'MY<K!A,>56L=_'QD*_AJJ."
MI"V&[XAJF*F)9]6V8W>LQ';6 'P61]L\7QS'%1(;E.RI%JF\:Q-<_6W^R6Q:
MXG>-NS](0,;"F=(C3H&%!?MSDX''UZ-4YL-?9*DRK*R%]78+I8I@#*V#^0/8
MHB9@NVL3T =[D7M;;H42LUDW:=<)&D$46OA*0KILE, *BE:Q2U1%VT](^'0-
MQXSA1<><&TR',M!E&7]R])!:"2"YG;M\ UV$,?'ONUW=^@&J>ZG +>47C$Y<
M/RVV"IIWK<M3+(%(DE;S 4FS<,QM$]=>@;9#E7'L?G,;@KMY:,MEX;.-J%NW
M-A [F:3$;8TCYS&OPZ#IO)L$KD2..-N &;LURN5Z1;H,T 6PC&=-LZ3\-=>@
M$R7.^)XVODK%W("I6(L*IY"=C"E=AXK-2MHC,D1BX--L3Z]!\X_SWB7(+C:.
M+R(MOI#R-HM!E>S"YG3?X'BMFW7MNVZ= 0CEW''\:;R=5T2P25.L-O;3VPJM
M)0TMLCO^GQE\/AT%5CFW%:\7)?D 7&/HKRMR2$XA=)N_8Z9V^D^(NT=^WIT%
M?'>?\1Y%<92Q.0AUU2H>51JVUW2F9TAHK>"S(->VX8TZ#0=!5:,0KL(O3;,:
M?Q[=2\-^N9VC.\DXK5Y5@$X>[I%5=I#+BIW1Y%I9!DO4)$AWQ\=>IKPU[I\L
M_DL;P#.. D6,JIZ;J*M/*N-)0YBJ#V,4:Y@X 6,6S8S4=-WU#'\O6G(.GVK<
M%\;A9$2D7JNPGQSLBX-X;+7_ '>IUUBC].\_'H./]IFR2V,RS&G:8MV;@I,1
M<Q>0#(1*-A"2="\HQH7H7Z= R/VY2["8G#6;9E3Q=VS8@U&U+S2Y=E:QERS%
MGD&+,;F;M3F)F?NZ!?2]KKRF5KSLMORE:4I&07(59J*IS3)7AB>Q$)F>L3I!
M3Z:1T%0^U%VFY3\;D5CX4T)&JY12G\NG82]S1VE$B-C\8=P_ M2^,] Q_P!L
MZ][+AE<ZU5][)MMM* #4KRV JI5XH@Y*!4JG _5,R4SKV].@4I]F?_C%47Y*
M9%*&I6:88J8,\=5H@4[&1N$9J2<@6HE$Z3'0>A_CV?Z5^-N5^3X/'NV?M>39
MIKX_[&O\ORZ#\]8@LZ[AV*Q^2365PNWS!Z[.129G>!D9EC$02B %K [0"LF"
M93 S]OR KG5W.Y7.<NY9B\':R,<6M4DX;)*96%29P;)M9 9!C0<7D)K%%L M
M=-.@=<OQ[^5>XR,GQMP1EJW%ZV9XW:+[9<-XC "G_MV%&2C_ +I=!GOZ_6Y#
MA>29JN!)7=YGQLSKL[,2T8QH-2R/@:F 0%^L=!Z-[CE7=SSV^K4)&>1*R;+!
M;-/*&+BJX;DGIW%1E*Q[]I+3X]!YKBU^XT__ ,Z94JMC#QQ[^F9B94U%J;O@
M\EGR1Y!="M_KMG9I^G0&\M_T?//_ ,\Q_P#Y7.@U/'3SMKW2P(\J35I6:6!L
M-X]&/,W*L"TT+M^9K02<&J(7M7 :?5);ITTZ#UKH!;7[MA5>/2)\C/X1Z=9O
M6X=_7\=;M^S/\_FQ7PQ6$7XQPRU,V&$3EB8B<3*B:B):J&1]/D#O'3BLR^6N
M.\X8\,IS2[=IV<7%VM(6$64XRT9D+%#B 851S&?]QDE&\N\,T*>^L=:<@^-Y
M5E8I)R&6'(L9*T/PV.-UJG+X999YH.5"4LL!](^%G;;$>D3,] YXU>YP>4XZ
M.1/7&MLY46&).EQBLF^#\@2& @8B(V]_EIT'I/03H)T$Z"=!.@43Q'C4X<\-
M..3_ $MCILG4V_1+I?\ DRS_ *O-]>OSZ K'X3$XZ@>/I55HI,-K&(&/I([!
MDQI%KZR9G,SK\^@'Q?%N/8IM=N.H*K,J5!Q]8PB=0J 6\4CK/V07>(Z :WP/
MAUNGD:=C$UV5<M9B[D52.D.LCMT<6FGU_0,Z]!;Q_AG%>.RTL)BZ]%KXB'N4
M$>5D1Z0;)U,HCX:ST%RN,8!. 9QY5%081JVH90B/VB6^2EHS'R/>6O\ 'H*K
M'#^,V1MB_')8-ZF&-N1,?XE->[8@O[@^0O\ GT!;<)B6W:%YE597,8+ H/F/
MJ2+A@&"$_(A&(G^'0&&8@$D4Z",:S/19,W >D!3!V#C0W3K$?(?A'6=?RZ^V
M_P!9V+N3<BC#TTL2B+EFU:1237\GCB3L,A<21P+-(C76?IGJY<_&E%+G--/T
M74/H-&[_ $U]9HDU:[)0N5C#UQ(;6P\)"2TUW:>NO6>LX=KX[3Y<ON+]T./W
MZM-\BVH5TR!2;2V+,=K_ ,>"9],P &W01(ITF>WKKU<L?YS&<C<URYV.Q",P
MG'E<QI["<T&BLQ6TA )6LX@C,I/L':?AZZ1U<LW6=J$I\\??>]%'&;R);K&,
M8UXK7815L?C/81;2E6TI$HB8G49CTG6(K#O&^X5+(7\#4KTW;LW6_*,RVP-;
M<F7J6S37<3! IC;\(U])C4#%\EO/O9NA5QNZWB30*Q:\%@X'AOAFZ(/9$=_6
M)G].@7V/<,!P6+R=3&MLNRE9MT:<F"R"O67#'%OG42^X8#3[IF.\1W@&N$Y.
MK+92[357)::U>G;KV2(9AZ;HLD"@8[CIXICOT#KH/)."9:S9Y9-;E^>RF.YK
M%FT0\=:4(QEBL)'"OPAE?CL+A.TI(3EF[7=\N@RY<QY_.+XE;Q=Y]S(1E.2N
MLT2*2_.KXRRZ1J3^O@"15\BV]!H\Q[L%2O\ (>2XQY9#"JXMC,GB*1%,**S<
MMVDA)1'VR10L3^,:?IT#A%&I@<KB#Y;[@6XY'<,#BB=FO5IV6$4!*$T_'IX]
MY0(]Y/\ O:] MXQ[MX'&9/E^.Y+EG_E5,_<527*++X75%:O& DI;!@8F2[:]
M!I_9G+9'+^UW',ED;)V[UJI#'V6SN,RDB[E/\.@V?029B(UF=(Z$@6Q,O:-8
M?MC0G3^GPC_CUF]>CMI\9Y?POE(3]WU1\I]/^7IU<.?E2SDF)QM_&@%RT6/5
M5>FVNVLEKE;4'!@6K1-?W1_-'52W)$[V^XG9MU0.XYEY)_FG,O W/.7*?YF0
M0E/WUUQJ$#],;/M[=$=?[?<1393:)T[\9)E/FE#(!+739A1^192  9%(%$P>
MD_=IT66S@5E>*4[U7%V"S%P5XG_,)?#DD#3@8@7.\JV 9#&LB7;29UCOI/4P
MUY9Y+V\$XG<.]CDY1ZWV((&546%2:$,?^2]"PD3D5-;/[D%$ZQ]/V]NJP87>
M"\7\R,M:B%9*B)S_ %G1*7ZE7FMY6&( &X%S]/TQ Z1\N@YR_'./7AR-1N4;
M5?G%(*U*;"@:Q%8=/IW"7T&$3#.VDQKT%>0XI@,A7E=G+O*<>KP-<#D*E234
M2VK*%@(+%RY^K08^V)';,:] [QN*Q->\^[1*-[Z]:L0 42 IK>24[8CT[.G^
M,:= RZ# 6>&\YSN7PQ\GR&,G&8*^&3KSCJSUV7N2)BH3EK6"H/K^O;NW>G:.
M@HXW[7Y'$W.,V&W4L'!7<Y;= B42P<NUAK$=?BOR?5K_ ,.@'J^R6.#,<O"P
M_?QKD],:J,<&HLJ$36V'>(M-('SOEJ_[,SZ:=!UD."^Y>6I8["9C-XRWB\?=
MI7"R<57KOO&A8!X"80V4P9^.((X[?';T&HX;Q6S@#Y"3W@[^LYBSE%;(F-@6
M 6, 6O\ -'C^'0??;KB]GBO",1QZRX+#\:CPL>N)@"G=,ZQ!=_CT&B(H$9(I
MTB(UF?X=%DR%EI0,-.-6GV0GY:_^._6<NTU[3CO5U9/B"=T[F'.YA?.>K(Y[
M[YOZ+>JP3<NF_&"?&/Q09BZ4B**;/%XX*2B/*<.(!D5_=I$ZSII'SZ#'HXYD
M4V<+41A+::F$Q\PC* 5$;C;4U65Q61^8O&*Q*=(T(9.1_E#N%^>XCEW/S[J5
M/0,B6';N7*(>PJ;B.P8BS]DG".W3R_07I.L= JR/!>97N!NP*X%?^7=+:5D@
ME5DBFP: CP&(J9O8!NC_  Y+2 ^B)CH-CAL!:_\ LUC-9"LE3D55TJ9J@=3D
MQ%MM\S&I?6R  8*== _O= HRO'>8/&V=UJ\M37E:ET,:"Q5+ZZ5J@P'RN)<:
M&,E 'I$D.NL:] %@.%Y:K:QB7TCA+*QULU#2K,J12(;$JK(F)FR+%38%>H[0
MD8GU[=!\S'$<O9Y#=R%;%%- )I>2HV:@S9"I<AQK1XRB# PU9/Y,P6^('6!D
MN@U/!>/EAL& /KC6NO)C'* MT+ FF:$ZQ]/[*C%?T]NW;H-%T$Z"=!.@G03H
M)T%=G_3L]/MGU].I>&_7]HH3_K3_ .F/O^[_ -/Z=2<NFWT@OK3@G03H)T$Z
.."=!.@G03H)T$Z"=!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>drr0702_ex99-1img03.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 drr0702_ex99-1img03.jpg
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M1+"9<6\,FUE>)40 "A:X?'+!,IB)].O3E\/Y-?;3_+IR'R?^S]SG>??M"AH
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M?<8!Y+!IWDAGVQU_5K:=5L<\97JSEEY1PQZ(LL9QCE6+YM<S[2KY-=ZO"6F
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BI8'&_P"YDFJ8#0!H T : - &@#0!H T : - &@#0!H#_V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
